Bryan Hubbard links ibogaine policy momentum to a recent executive order, veteran-focused treatment efforts, and next-step government pathways in the United States

Ibogaine is moving closer to mainstream US policy attention through veteran-focused treatment advocacy, a recent executive order, and growing interest in how government could support research and access pathways. Bryan Hubbard frames ibogaine as a high-stakes option for addiction, trauma, and brain injury-related care, especially where existing treatments fall short. Government action appears to hinge on whether policymakers treat ibogaine as a national health and readiness issue rather than a fringe drug topic. The discussion connects federal momentum with wider networks that include clinics abroad, political strategy, and efforts to translate anecdotal and early clinical promise into regulated programs. Gabon and the spiritual-cultural roots of iboga also sit in the background, highlighting tensions between Indigenous knowledge, medicalization, and US state interests. What comes next depends on evidence generation, executive follow-through, and whether public institutions can build credible pathways for safety, legitimacy, and scale.